It gives me immense pleasure to reflect on the landmark participation of India at the BIO International Convention 2025, held in Boston, MA, USA. The India Pavilion, led by ABLE in partnership with BIRAC, State Governments, and a wide range of biotech stakeholders, drew global attention and appreciation. We were honoured to be joined at the inaugural by Dr. Kiran Mazumdar-Shaw, Dr. Jitendra Kumar, and senior government officials, reinforcing India’s growing stature as a global innovation hub.

A series of high-impact engagements accompanied the Pavilion this year-

- A fireside chat with top leadership highlighted India’s strengths in synthetic biology, medtech, and biomanufacturing

- A delegation visit to Manus, a cutting-edge biofoundry, demonstrated India's interest in next-generation industrial biotech

- An interaction session at Harvard Medical School with Indian student innovators and diaspora entrepreneurs emphasized talent-driven collaboration across borders.

- Startups delegation on exposure visit to Boston & New Jersey with BIO 2025 as a centre point.

In recognition of the Pavilion’s success and increasing interest from States and industry alike, I’m delighted to announce that ABLE will have larger India Pavilion at BIO 2026 in San Diego. The expanded space will offer exhibitors enhanced facilities such as dedicated zones for private B2B meetings, and fireside discussions, Stronger country branding with unified national storytelling, Seamless support for startups, MSMEs, and first-time global participants.

The Pavilion continues to be hosted on a not-for-profit basis, focused on amplifying India's voice on the world stage and enabling cross-border collaboration in research, regulation, and market access. As ABLE prepares to take India’s presence even further in 2026, I invite more stakeholders—government bodies, academic institutions, startups, and industry leaders—to join hands in showcasing India’s global biotech leadership.

On a special note, we extend our heartfelt congratulations to Dr. Pankaj Patel, Chairman of Zydus Lifesciences, on being conferred the Padma Bhushan—a recognition richly deserved for his decadeslong contribution to India’s pharma and biotech industries.

We are also pleased to announce that we are discussing with the organisers of SynBioBeta for having a similar INDIA Pavilion to support our Bio Industrial companies participation. We are also exploring the few BioPharma events in Germany in October.

Let us continue to work together to build a stronger, sustainable, and inclusive bioeconomy.

Happy reading!